Cargando…

Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15

Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huei-Mei, Resendes, Rachel, Ghodssi, Azita, Sookiasian, Danielle, Tian, Michael, Dollive, Serena, Adamson-Small, Laura, Avila, Nancy, Tazearslan, Cagdas, Thompson, John F., Ellsworth, Jeff L., Francone, Omar, Seymour, Albert, Wright, Jason B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250422/
https://www.ncbi.nlm.nih.gov/pubmed/32453743
http://dx.doi.org/10.1371/journal.pone.0233373
_version_ 1783538760266285056
author Chen, Huei-Mei
Resendes, Rachel
Ghodssi, Azita
Sookiasian, Danielle
Tian, Michael
Dollive, Serena
Adamson-Small, Laura
Avila, Nancy
Tazearslan, Cagdas
Thompson, John F.
Ellsworth, Jeff L.
Francone, Omar
Seymour, Albert
Wright, Jason B.
author_facet Chen, Huei-Mei
Resendes, Rachel
Ghodssi, Azita
Sookiasian, Danielle
Tian, Michael
Dollive, Serena
Adamson-Small, Laura
Avila, Nancy
Tazearslan, Cagdas
Thompson, John F.
Ellsworth, Jeff L.
Francone, Omar
Seymour, Albert
Wright, Jason B.
author_sort Chen, Huei-Mei
collection PubMed
description Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitative molecular characterization of the edited sequence that overcome technical obstacles such as excess episomal vector genomes and lengthy homology arms. Here we describe a novel molecular methodology that utilizes quantitative next-generation sequencing to characterize AAV-mediated targeted insertion and detects the presence of unintended mutations. The methods described here quantify targeted insertion and query the entirety of the target locus for the presence of insertions, deletions, single nucleotide variants (SNVs) and integration of viral components such as inverted terminal repeats (ITR). Using a humanized liver murine model, we demonstrate that hematopoietic stem-cell derived AAVHSC15 mediates in vivo targeted gene integration into human chromosome 12 at the PAH (phenylalanine hydroxylase) locus at 6% frequency, with no sign of co-incident random mutations at or above a lower limit of detection of 0.5% and no ITR sequences at the integration sites. Furthermore, analysis of heterozygous variants across the targeted locus using the methods described shows a pattern of strand cross-over, supportive of an HR mechanism of gene integration with similar efficiencies across two different haplotypes. Rapid advances in the application of AAV-mediated nuclease-free target integration, or gene editing, as a new therapeutic modality requires precise understanding of the efficiency and the nature of the changes being introduced to the target genome at the molecular level. This work provides a framework to be applied to homologous recombination gene editing platforms for assessment of introduced and natural sequence variation across a target site.
format Online
Article
Text
id pubmed-7250422
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72504222020-06-08 Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 Chen, Huei-Mei Resendes, Rachel Ghodssi, Azita Sookiasian, Danielle Tian, Michael Dollive, Serena Adamson-Small, Laura Avila, Nancy Tazearslan, Cagdas Thompson, John F. Ellsworth, Jeff L. Francone, Omar Seymour, Albert Wright, Jason B. PLoS One Research Article Targeted gene integration via precise homologous recombination (HR)-based gene editing has the potential to correct genetic diseases. AAV (adeno-associated virus) can mediate nuclease-free gene integration at a disease-causing locus. Therapeutic application of AAV gene integration requires quantitative molecular characterization of the edited sequence that overcome technical obstacles such as excess episomal vector genomes and lengthy homology arms. Here we describe a novel molecular methodology that utilizes quantitative next-generation sequencing to characterize AAV-mediated targeted insertion and detects the presence of unintended mutations. The methods described here quantify targeted insertion and query the entirety of the target locus for the presence of insertions, deletions, single nucleotide variants (SNVs) and integration of viral components such as inverted terminal repeats (ITR). Using a humanized liver murine model, we demonstrate that hematopoietic stem-cell derived AAVHSC15 mediates in vivo targeted gene integration into human chromosome 12 at the PAH (phenylalanine hydroxylase) locus at 6% frequency, with no sign of co-incident random mutations at or above a lower limit of detection of 0.5% and no ITR sequences at the integration sites. Furthermore, analysis of heterozygous variants across the targeted locus using the methods described shows a pattern of strand cross-over, supportive of an HR mechanism of gene integration with similar efficiencies across two different haplotypes. Rapid advances in the application of AAV-mediated nuclease-free target integration, or gene editing, as a new therapeutic modality requires precise understanding of the efficiency and the nature of the changes being introduced to the target genome at the molecular level. This work provides a framework to be applied to homologous recombination gene editing platforms for assessment of introduced and natural sequence variation across a target site. Public Library of Science 2020-05-26 /pmc/articles/PMC7250422/ /pubmed/32453743 http://dx.doi.org/10.1371/journal.pone.0233373 Text en © 2020 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Huei-Mei
Resendes, Rachel
Ghodssi, Azita
Sookiasian, Danielle
Tian, Michael
Dollive, Serena
Adamson-Small, Laura
Avila, Nancy
Tazearslan, Cagdas
Thompson, John F.
Ellsworth, Jeff L.
Francone, Omar
Seymour, Albert
Wright, Jason B.
Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
title Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
title_full Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
title_fullStr Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
title_full_unstemmed Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
title_short Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
title_sort molecular characterization of precise in vivo targeted gene integration in human cells using aavhsc15
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250422/
https://www.ncbi.nlm.nih.gov/pubmed/32453743
http://dx.doi.org/10.1371/journal.pone.0233373
work_keys_str_mv AT chenhueimei molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT resendesrachel molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT ghodssiazita molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT sookiasiandanielle molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT tianmichael molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT dolliveserena molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT adamsonsmalllaura molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT avilanancy molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT tazearslancagdas molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT thompsonjohnf molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT ellsworthjeffl molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT franconeomar molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT seymouralbert molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15
AT wrightjasonb molecularcharacterizationofpreciseinvivotargetedgeneintegrationinhumancellsusingaavhsc15